60% Alzheimer Cases Go Undiagnosed

Almost 60% of Alzheimer cases and other forms of dementia go undiagnosed as 2/3 adults cannot differentiate between normal signs of aging and the symptoms of dementia.

Almost 60% of Alzheimer cases and other forms of dementia go undiagnosed as 2/3 adults cannot differentiate between normal signs of aging and the symptoms of dementia. Around 1/3 people feel there is no support for victims of dementia. Due to this about 4,00,000 families fail to get vital help from the NHS. The Department of Health has found that against the 6,34,000 victims hardly 2,50,000 dementia patients are registered by GP's.

This information has been revealed as part of the government's advertising campaign in England aimed at encouraging early diagnosis. The ad campaign shows a daughter's dilemma as she realizes that her father is affected by memory loss.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

Experts have urged family members to look out for warning signs of dementia like anxiety, confusion or memory loss in elderly relatives when they visit them this festive season. This helps in early diagnosis. Early intervention slows down the progression of the disease. This helps the affected to plan the future, reduce care home admissions and improve the patient's as well as the entire family's quality of life.

Source-Medindia

Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.

Daily Vit B Pill Can Help to Keep Alzheimer's Disease at Bay
A daily dose of vitamin B could greatly slow the onset of dementia and guard against Alzheimer's disease.

Mastinib as Add-on Treatment Improves Patients With Alzheimer's Disease
Masitinib has proved to be highly beneficial in treating mild to moderate Alzheimer’s disease. The prognosis was found to be better with masitinib as compared to placebo administration.